(Circulation. 2000;101:2118.)
© 2000 American Heart Association, Inc.
Current Perspective |
From the National Heart, Lung, and Blood Institutes Framingham Heart Study, Framingham, Mass (R.S.V., D.L.); the Divisions of Cardiology and Clinical Epidemiology, Beth Israel Hospital, Boston, Mass (D.L.); the Department of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Mass (R.S.V., D.L.); and the National Heart, Lung, and Blood Institute, Bethesda, Md (D.L.).
Correspondence to Ramachandran S. Vasan, MD, Framingham Heart Study, 5 Thurber Street, Framingham, MA 01702. E-mail vasan{at}fram.nhlbi.nih.gov
Key Words: heart failure diastole echocardiography imaging diagnosis
| Introduction |
|---|
|
|
|---|
Several hospital-based reports have documented that a high proportion
of patients with CHF have normal left ventricular (LV)
systolic function,5 and 4 different
epidemiological investigations further confirmed that nearly half of
CHF subjects in the community have normal LV systolic
function.6 7 8 9 This condition is commonly referred to as
diastolic heart failure (DHF). Hospital readmission rates
for patients with DHF are similar to those for patients with
systolic heart failure (SHF),10 and it is
estimated that DHF accounts for
25% of the total cost of CHF, which
is estimated at $15 to $40 billion annually.4 11 A
distinction between DHF and SHF is important because DHF is associated
with better long-term survival5 and because these 2 forms
of heart failure require different therapeutic approaches.
Although the societal burden of DHF is high and its economic impact substantial, it is intriguing that most national and international guidelines either do not consider the condition12 13 or underscore that a paucity of information about it precludes any definitive therapeutic recommendations.14 Numerous clinical trials have documented the benefits of treatment for SHF; however, the optimal treatment for DHF has not yet been defined. The first step toward evaluating any potential treatment for DHF is to develop uniform criteria for its diagnosis. This task, however, is complicated by the pathophysiological heterogeneity of DHF11 and by the limitations of currently available noninvasive modalities for diagnosing LV diastolic dysfunction.5
| Diagnosis of Congestive Heart Failure: Role of Imaging Studies and Related Biases |
|---|
|
|
|---|
Recently, the European Society of Cardiology proposed
guidelines for the diagnosis of CHF.17 These guidelines
require objective evidence of LV dysfunction for a diagnosis of CHF.
This requirement for evidence of LV dysfunction stemmed from evidence
of inaccuracies in the clinical diagnosis of CHF, especially in women,
the elderly, and the obese.18 19 Other investigators have
also supported the need for an imaging study to assess LV function as a
part of the diagnosis of CHF.20 21 We think that although
the assessment of LV systolic function is critical in
determining the optimal treatment for patients with CHF, the diagnosis
of CHF is clinical and should not be made on the basis of LV ejection
fraction (EF). Furthermore, for some research studies, the diagnosis of
CHF should be made with the physician blinded to LV systolic
function to avoid potential diagnostic biases. Requiring
objective evidence of LV dysfunction to diagnose CHF would inevitably
lead to an underestimation of the occurrence of DHF in the community.
This is because although definitive evidence of LV systolic
dysfunction is easily obtained from the LVEF, unequivocal evidence of
LV diastolic dysfunction is difficult to obtain by
noninvasive methods (see below). Consider an elderly patient
presenting with exertional dyspnea, paroxysmal nocturnal dyspnea,
and pedal edema. If the LVEF=0.30, a diagnosis of SHF is readily
accepted by the clinician. However, if the LVEF
0.50, the diagnosis of
CHF may be doubted. The existence of such clinical biases in diagnosis
can result in a systematic and serious underestimation of DHF in the
community. In this context, it is important to emphasize that the signs
and symptoms of CHF correlate poorly, if at all, with
LVEF.22 23 Thus, a normal LVEF should not be used to
reject a diagnosis of CHF if the clinical presentation is
convincing. Legitimate concerns about false-positive diagnoses of CHF
can be adequately addressed by requiring clinicians to consider
carefully and to rule out alternative diagnoses that can masquerade as
CHF before making a diagnosis of CHF.24
| Proposed Criteria for DHF According to Degree of Diagnostic Certainty |
|---|
|
|
|---|
1 of these indices for the
presence of LV diastolic dysfunction is currently
unknown.
We propose a classification schema for DHF by which patients are
categorized according to the degree of diagnostic
certainty. This classification approach (Tables 1 to 3![]()
![]()
)
is applicable to patients who do not have CHF attributable to
valvular heart disease, cor pulmonale, or a primary volume
overload state. A patient who meets the following 3 conditions, in this
hierarchical fashion, has definite DHF (Table 1
):
|
|
|
The first step in the diagnosis of DHF is to establish a diagnosis
of CHF. Definitive evidence of CHF in a hospital-based setting
typically consists of the presence of signs and symptoms compatible
with a diagnosis of CHF, laboratory tests (such as a chest X-ray) that
support this diagnosis, and a typical clinical response to treatment
with diuretics; documentation of elevated LV filling
pressures or a low cardiac index may or may not also be
present.16 The second step in establishing a diagnosis
of DHF is to document normal LV systolic function in proximity
to the episode of CHF. An LVEF
0.50, obtained either by
echocardiography or with radionuclide angiography,
is evidence of normal LV systolic function.5 26
Definitive objective evidence of ventricular
diastolic dysfunction requires cardiac
catheterization.27 28 This would typically
involve demonstrating an increased LV end-diastolic filling
pressure in the presence of a normal or reduced LV
end-diastolic volume.
Often, when the first 2 criteria are fulfilled, it is not
possible to obtain objective evidence of LV diastolic
dysfunction. It is not feasible to subject all CHF patients to cardiac
catheterization. Furthermore, even when cardiac
catheterization is performed, typically, patients are
clinically stabilized and well diuresed before the procedure; these
circumstances influence the sensitivity of the test procedure itself.
In addition, currently available noninvasive assessments of LV
diastolic function are imprecise. Under these
circumstances, we think that it is reasonable to accept that the cause
of CHF in patients with a normal LVEF is probably LV
diastolic dysfunction once mitral valve disease, cor
pulmonale, primary volume overload conditions, and noncardiac causes of
symptoms are excluded.24 29 These patients can be
categorized as having probable DHF (Table 2
); it is highly
probable that LV diastolic dysfunction is the basis of
their clinical symptoms.
A third category exists, that of patients who have a history of
CHF, currently have normal LV systolic function (ie, LV
function was not obtained in proximity to the CHF event), and who have
not undergone an evaluation of LV diastolic function. We
suggest that such patients be considered to have possible DHF (Table 3
). Less diagnostic certainty exists in such
patients compared with subjects in the second category because these
patients may have had transient LV systolic dysfunction during
the episode of acute CHF.
A diagnosis of possible DHF can be upgraded to probable DHF if
the clinical setting is typical for the presence of LV
diastolic dysfunction (Table 4
). The presence of markedly
elevated blood pressure during the episode of CHF favors a diagnosis of
DHF30 because a failing LV with systolic
dysfunction is more likely to result in a normal or low blood
pressure.31 Echocardiographic evidence of
moderate concentric hypertrophy without concomitant wall
motion abnormalities increases the likelihood of DHF.24 A
transient fall in LVEF during the episode of CHF with a subsequent
rebound is unlikely in the presence of LV hypertrophy and
in the absence of significant ischemia.32 The
presence of a tachyarrhythmia with shortened
diastolic filling or atrial fibrillation, with a resultant
loss of the atrial "kick" during the episode of CHF, increases the
likelihood of DHF. In these settings, subclinical LV
diastolic dysfunction was likely unmasked by the rapid
heart rate.28 A left ventricle with normal
systolic and diastolic function is unlikely to fail
due to an acute increase in heart rate. Likewise, the onset of CHF
after the administration of a small amount of intravenous
fluid in a patient with a normal LVEF suggests a diagnosis of probable
DHF (with underlying LV diastolic dysfunction) because
individuals with normal LV systolic and diastolic function
can tolerate a considerable volume load without developing CHF. If
symptoms in a patient with possible DHF improve with treatment directed
at the underlying cause of diastolic dysfunction (such as
lowering blood pressure, controlling a rapid heart rate, or restoring
atrioventricular synchrony), the diagnosis may be
upgraded to probable DHF to indicate an increase in
diagnostic certainty.
|
Epidemiological studies use scoring systems for establishing a diagnosis of CHF.33 These approaches combine clinical symptoms and signs with laboratory tests to yield a "heart failure score," which is then used to establish the presence or absence of CHF. If LV systolic function is normal, the heart failure score suggests the presence of CHF and, if a noncardiac cause of symptoms is not present, a diagnosis of possible DHF can be made. It must be underscored that a greater degree of diagnostic certainty may not be achievable in epidemiological settings in which subjects are evaluated at varying times after the onset of CHF.
A diagnosis of DHF is doubtful if heart failure symptoms can be explained by another diagnosis or if objective evidence of normal LV systolic function is lacking. In the first instance, it is likely that the diagnosis of CHF is incorrect. In the second case, the possibility exists of falsely diagnosing LV diastolic dysfunction when LV systolic dysfunction is present. Findings associated with an increased probability of SHF include an abnormal apical impulse (especially sustained duration)30 31 and electrocardiographic evidence of an old anterior Q-wave myocardial infarction or a left bundle branch block pattern.30
| Causes of DHF |
|---|
|
|
|---|
| Validity of Proposed Criteria and Limitations |
|---|
|
|
|---|
The validity of the content of the proposed classification merits comment. The construction of a sensible, criterion-based classification system relies on judgment regarding the choice of the constituent criteria for CHF and for DHF. We selected 3 criteria that, in our judgment, make pathophysiological sense, and we proposed a simple hierarchical system of 3 categories indicating different degrees of diagnostic certainty. Similar diagnostic categories have been used for classifying other disorders for which a variable degree of clinical certainty exists and for which no gold standard for diagnosis exists.34 35 The proposed categorization system requires prospective validation; its accuracy (misclassification rate) is presently unknown.
| Future Directions |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. L. Handoko and W. J. Paulus Polishing the diastolic dysfunction measurement stick Eur J Echocardiogr, June 11, 2008; (2008) jen181v1. [Full Text] [PDF] |
||||
![]() |
M. St John Sutton Quest for Diastolic Prognostic Indicators of Clinical Outcome After Acute Myocardial Infarction Circulation, May 20, 2008; 117(20): 2570 - 2572. [Full Text] [PDF] |
||||
![]() |
M. Guazzi, R. Arena, and M. D. Guazzi Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1357 - H1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Souliere, F. Levy, M. Peltier, M. Slama, and Z. Massy Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur. Heart J., February 1, 2008; 29(3): 339 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.A. Connelly, D.J. Kelly, Y. Zhang, D.L. Prior, J. Martin, A.J. Cox, K. Thai, M.P. Feneley, J. Tsoporis, K.E. White, et al. Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat Cardiovasc Res, November 1, 2007; 76(2): 280 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur. Heart J., October 2, 2007; 28(20): 2539 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Gaasch and W. C. Little Assessment of Left Ventricular Diastolic Function and Recognition of Diastolic Heart Failure Circulation, August 7, 2007; 116(6): 591 - 593. [Full Text] [PDF] |
||||
![]() |
R. Pirracchio, B. Cholley, S. De Hert, A. C. Solal, and A. Mebazaa Diastolic heart failure in anaesthesia and critical care Br. J. Anaesth., June 1, 2007; 98(6): 707 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, F. Bursi, B. A. Borlaug, S. R. Ommen, D. A. Kass, and M. M. Redfield Cardiac Structure and Ventricular-Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota Circulation, April 17, 2007; 115(15): 1982 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Nishimura and W. Jaber Understanding "Diastolic Heart Failure": The Tip of the Iceberg J. Am. Coll. Cardiol., February 13, 2007; 49(6): 695 - 697. [Full Text] [PDF] |
||||
![]() |
T Weber, J Auer, M F O'Rourke, C Punzengruber, E Kvas, and B Eber Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction Heart, November 1, 2006; 92(11): 1616 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-M. Yu, Q. Zhang, G. W.K. Yip, P.-W. Lee, L. C.C. Kum, Y.-Y. Lam, and J. W.-H. Fung Diastolic and Systolic Asynchrony in Patients With Diastolic Heart Failure: A Common but Ignored Condition J. Am. Coll. Cardiol., October 31, 2006; (2006) j.jacc.2006.10.022v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghio Role of echo Doppler techniques in the evaluation and treatment of heart failure patients Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E28 - E31. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Owan, D. O. Hodge, R. M. Herges, S. J. Jacobsen, V. L. Roger, and M. M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med., July 20, 2006; 355(3): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Bhatia, J. V. Tu, D. S. Lee, P. C. Austin, J. Fang, A. Haouzi, Y. Gong, and P. P. Liu Outcome of heart failure with preserved ejection fraction in a population-based study. N. Engl. J. Med., July 20, 2006; 355(3): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Aurigemma Diastolic heart failure--a common and lethal condition by any name. N. Engl. J. Med., July 20, 2006; 355(3): 308 - 310. [Full Text] [PDF] |
||||
![]() |
A. F Leite-Moreira Current perspectives in diastolic dysfunction and diastolic heart failure. Heart, May 1, 2006; 92(5): 712 - 718. [Full Text] [PDF] |
||||
![]() |
R. Dhingra, M. J. Pencina, T. J. Wang, B.-H. Nam, E. J. Benjamin, D. Levy, M. G. Larson, W. B. Kannel, R. B. D'Agostino Sr, and R. S. Vasan Electrocardiographic QRS Duration and the Risk of Congestive Heart Failure: The Framingham Heart Study Hypertension, May 1, 2006; 47(5): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. van Heerebeek, A. Borbely, H. W.M. Niessen, J. G.F. Bronzwaer, J. van der Velden, G. J.M. Stienen, W. A. Linke, G. J. Laarman, and W. J. Paulus Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure Circulation, April 25, 2006; 113(16): 1966 - 1973. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kamp Advanced Systolic and Diastolic Function: Beyond the E-and A-wave Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 63 - 65. [Abstract] [PDF] |
||||
![]() |
R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Aurigemma, M. R. Zile, and W. H. Gaasch Contractile Behavior of the Left Ventricle in Diastolic Heart Failure: With Emphasis on Regional Systolic Function Circulation, January 17, 2006; 113(2): 296 - 304. [Full Text] [PDF] |
||||
![]() |
M. Guazzi, J. Myers, and R. Arena Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1883 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmed Association of Diastolic Dysfunction and Outcomes in Ambulatory Older Adults With Chronic Heart Failure J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1339 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tendera Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J5 - J9. [Abstract] [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the American Colle, Endorsed by the Heart Rhythm Society, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1116 - 1143. [Full Text] [PDF] |
||||
![]() |
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society Circulation, September 20, 2005; 112(12): 1825 - 1852. [Full Text] [PDF] |
||||
![]() |
H. Ashikaga, J. W. Covell, and J. H. Omens Diastolic dysfunction in volume-overload hypertrophy is associated with abnormal shearing of myolaminar sheets Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2603 - H2610. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Mottram and T. H Marwick Assessment of diastolic function: what the general cardiologist needs to know Heart, May 1, 2005; 91(5): 681 - 695. [Full Text] [PDF] |
||||
![]() |
J. Rysa, H. Leskinen, M. Ilves, and H. Ruskoaho Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure Hypertension, May 1, 2005; 45(5): 927 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Varela-Roman, L Grigorian, E Barge, P Bassante, M G de la Pena, and J R Gonzalez-Juanatey Heart failure in patients with preserved and deteriorated left ventricular ejection fraction Heart, April 1, 2005; 91(4): 489 - 494. [Abstract] [Full Text] |